FNA vs. IRTC, NVST, PRCT, LIVN, TMDX, ENOV, WRBY, NVCR, LMAT, and TNDM
Should you be buying Paragon 28 stock or one of its competitors? The main competitors of Paragon 28 include iRhythm Technologies (IRTC), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), TransMedics Group (TMDX), Enovis (ENOV), Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry.
Paragon 28 vs.
Paragon 28 (NYSE:FNA) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, community ranking, analyst recommendations, valuation, media sentiment and institutional ownership.
63.6% of Paragon 28 shares are owned by institutional investors. 15.3% of Paragon 28 shares are owned by insiders. Comparatively, 0.7% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
iRhythm Technologies received 374 more outperform votes than Paragon 28 when rated by MarketBeat users. However, 74.47% of users gave Paragon 28 an outperform vote while only 66.07% of users gave iRhythm Technologies an outperform vote.
In the previous week, Paragon 28 and Paragon 28 both had 5 articles in the media. iRhythm Technologies' average media sentiment score of 0.79 beat Paragon 28's score of 0.25 indicating that iRhythm Technologies is being referred to more favorably in the news media.
Paragon 28 has higher earnings, but lower revenue than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Paragon 28, indicating that it is currently the more affordable of the two stocks.
Paragon 28 currently has a consensus price target of $14.20, indicating a potential upside of 9.06%. iRhythm Technologies has a consensus price target of $119.73, indicating a potential upside of 9.74%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than Paragon 28.
Paragon 28 has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500.
iRhythm Technologies has a net margin of -19.14% compared to Paragon 28's net margin of -25.31%. Paragon 28's return on equity of -37.90% beat iRhythm Technologies' return on equity.
Summary
iRhythm Technologies beats Paragon 28 on 9 of the 17 factors compared between the two stocks.
Get Paragon 28 News Delivered to You Automatically
Sign up to receive the latest news and ratings for FNA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Paragon 28 Competitors List
Related Companies and Tools
This page (NYSE:FNA) was last updated on 3/4/2025 by MarketBeat.com Staff
Free FNA Stock Alerts